Article History
Received: 13 October 2023
Accepted: 4 January 2024
First Online: 19 January 2024
Declarations
:
: All animal studies were conducted under the animal-use protocol and animal welfare policy of WuXi App Tec.
: Not applicable.
: RD is the inventor of iMN013 and iMN041 and majority shareholder of Epigenetics Pharma.